- Home
- CMU vs STIM Comparison
CMU vs STIM Comparison
Compare CMU & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMU
- STIM
- Stock Information
- Founded
- CMU 1987
- STIM 2003
- Country
- CMU United States
- STIM United States
- Employees
- CMU N/A
- STIM N/A
- Industry
- CMU Investment Managers
- STIM Medical/Dental Instruments
- Sector
- CMU Finance
- STIM Health Care
- Exchange
- CMU Nasdaq
- STIM Nasdaq
- Market Cap
- CMU 89.6M
- STIM 192.0M
- IPO Year
- CMU N/A
- STIM 2018
- Fundamental
- Price
- CMU $3.56
- STIM $4.36
- Analyst Decision
- CMU
- STIM Buy
- Analyst Count
- CMU 0
- STIM 4
- Target Price
- CMU N/A
- STIM $4.67
- AVG Volume (30 Days)
- CMU 82.4K
- STIM 1.7M
- Earning Date
- CMU 01-01-0001
- STIM 03-04-2025
- Dividend Yield
- CMU 4.08%
- STIM N/A
- EPS Growth
- CMU N/A
- STIM N/A
- EPS
- CMU 0.07
- STIM N/A
- Revenue
- CMU N/A
- STIM $72,711,000.00
- Revenue This Year
- CMU N/A
- STIM $3.23
- Revenue Next Year
- CMU N/A
- STIM $29.55
- P/E Ratio
- CMU $47.57
- STIM N/A
- Revenue Growth
- CMU N/A
- STIM 5.03
- 52 Week Low
- CMU $2.78
- STIM $0.52
- 52 Week High
- CMU $3.38
- STIM $5.07
- Technical
- Relative Strength Index (RSI)
- CMU 56.76
- STIM 73.44
- Support Level
- CMU $3.52
- STIM $2.80
- Resistance Level
- CMU $3.58
- STIM $3.65
- Average True Range (ATR)
- CMU 0.03
- STIM 0.47
- MACD
- CMU 0.00
- STIM 0.06
- Stochastic Oscillator
- CMU 73.75
- STIM 89.01
About CMU MFS Municipal Income Trust
Mfs High Yield Municipal Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowings for investment purposes, in tax-exempt bonds and tax-exempt notes.
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.